The Los Angeles Post
U.S. World Business Lifestyle
Today: March 24, 2025
Today: March 24, 2025
TOM MURPHY

TOM MURPHY

Staff Writer

Latest From TOM MURPHY

Business|Health|Political|US

More states requiring paid medical or sick leave

More states are passing or considering family medical leave laws that would require employers to offer paid leave for workers to undergo treatment or care for a sick family member

More states requiring paid medical or sick leave
Health|Political|US

Oz pledges to fight health care fraud but makes no commitments on Medicaid funding cuts

Dr. Mehmet Oz is promising to fight health care fraud and push to make Americans healthier if he becomes the next leader of the Centers for Medicare and Medicaid Services

Oz pledges to fight health care fraud but makes no commitments on Medicaid funding cuts
Business|Economy|Health|US

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Supplies of high-demand obesity treatments are improving, but that doesn’t mean they're easier to get

Patients struggle with lack of consistent coverage for popular weight-loss drugs
Business|Economy|Finance|Health|Stock Markets|US

UnitedHealth shares dive after report of US investigation into Medicare billing

UnitedHealth Group shares tumbled Friday on a report that the U.S. Department of Justice has started an investigation into the health care giant’s Medicare billing practices

Business|Finance|Health|Stock Markets|US

CVS Health steers through rising insurance costs in a strong fourth quarter

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy benefits manager dealt with rising costs in its insurance division

CVS Health steers through rising insurance costs in a strong fourth quarter
Business|Health|Science|Technology

GeneDx CEO wants genetic testing for every newborn

GeneDx is targeting a big market for its genetic testing: every newborn baby

Business|Economy|Finance|Health|Stock Markets|US

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
Business|Economy|Finance|Health|Stock Markets

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China

Shares of Merck are sliding in early trading after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China

Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China
Economy|Health|US

How to deal with fresh health insurance deductibles in the new year

Many Americans with high-deductible health insurance face a cold reality at the start of every year: Those deductibles will have to be paid before most insurance coverage starts

How to deal with fresh health insurance deductibles in the new year
Business|Finance|Stock Markets|US

Walgreens suspends dividend, breaking 90-plus year streak of shareholder payouts

Walgreens shares sank Friday, a day after the drugstore chain said it was suspending its dividend, breaking a streak of quarterly shareholder payouts that stretches back more than 90 years

Walgreens suspends dividend, breaking 90-plus year streak of shareholder payouts
Business|News|Technology

Johnson & Johnson is getting rid of its script logo after more than 130 years

Johnson & Johnson is signing off on a new logo, more than 130 years after creating the old one

Johnson & Johnson is getting rid of its script logo after more than 130 years
Health

Supply problems and insurance issues make popular weight-loss drugs hard to get

Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity

Supply problems and insurance issues make popular weight-loss drugs hard to get
Business|Lifestyle|News|US

New rules aim to make foster care with family easier, provide protection for LGBTQ+ children

The Biden administration is moving to make it easier for caregivers to take in family members in the foster care system, requiring states to provide them with the same financial support that any other foster home would receive

New rules aim to make foster care with family easier, provide protection for LGBTQ+ children
Business|Health|News|US

Pharmacist shortages and heavy workloads challenge drugstores heading into their busy season

Customers may need a dose of patience at U.S. pharmacy counters as those businesses start their busiest season

Pharmacist shortages and heavy workloads challenge drugstores heading into their busy season
Business|Economy|Health|News

Annual window to shop for Medicare Advantage plans returns on Sunday

Open enrollment for Medicare opens Sunday, and seniors could have dozens of options to choose from

Annual window to shop for Medicare Advantage plans returns on Sunday
Business|Economy|Finance|News

Rite Aid seeks Chapter 11 bankruptcy protection as it deals with lawsuits and losses

Rite Aid has filed for bankruptcy and plans to sell part of its business as it attempts to restructure while dealing with losses and opioid-related lawsuits

Rite Aid seeks Chapter 11 bankruptcy protection as it deals with lawsuits and losses
Business|Economy|Finance|Health|News

Rite Aid's bankruptcy plan stirs worries of new 'pharmacy deserts'

Rite Aid’s plan to close more stores as part of its bankruptcy process raises concern about how that might hurt access to medicine and care

Rite Aid's bankruptcy plan stirs worries of new 'pharmacy deserts'
Business|Technology

Amazon will start testing drones that will drop prescriptions on your doorstep, literally

Amazon will soon make prescription drugs fall from the sky when the e-commerce giant becomes the latest company to test drone deliveries

Amazon will start testing drones that will drop prescriptions on your doorstep, literally
Business|Economy|Health|US

Pharmacists prescribe another round of US protests to highlight working conditions

Drugstore employees around the country have started calling in sick to highlight a lack of support from their employers

Pharmacists prescribe another round of US protests to highlight working conditions
Business|Economy|Finance|Health|News

A continuing decline in sales of COVID-19 products clips revenue at Pfizer

Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue

A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Health|News

It's time to buy health insurance through the marketplace. Experts suggest doing your research first

The time to shop for health insurance on the Affordable Care Act’s coverage marketplaces is back

It's time to buy health insurance through the marketplace. Experts suggest doing your research first
Economy|Health|Lifestyle|News|US

In death, one cancer patient helps to erase millions in medical debt

A New York woman who died Sunday from cancer has raised enough money to erase million of dollars in medical debt with a posthumous plea for help

In death, one cancer patient helps to erase millions in medical debt
Business|Finance|Health

Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio

AbbVie is spending more than $10 billion to add a potential blockbuster cancer treatment as cheaper versions of the drugmaker’s all-time best seller, Humira, cut into sales

Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio
Business|Finance|Health|Stock Markets

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
Business|Finance|Health|News

Switch from selling COVID-19 drugs on market rather than to governments continues to sting at Pfizer

Pfizer’s forecast for sales of its COVID-19 vaccine and treatment next year falls more than $5 billion short of the Wall Street consensus

Switch from selling COVID-19 drugs on market rather than to governments continues to sting at Pfizer

Follow